Search

Your search keyword '"Nishigaki, R."' showing total 146 results

Search Constraints

Start Over You searched for: Author "Nishigaki, R." Remove constraint Author: "Nishigaki, R."
146 results on '"Nishigaki, R."'

Search Results

1. Characteristic endoscopic findings of gastrointestinal malignant lymphomas other than mucosa-associated lymphoid tissue lymphoma

2. A new mouse model for Down syndrome

Catalog

Books, media, physical & digital resources

4. A new mouse model for Down syndrome

7. A new mouse model for Down syndrome

11. Contribution of pharmacists with expertise in infectious diseases to appropriate individualized vancomycin dosing

12. Risk factors for development of postoperative hypertension

14. Proteomic signatures and aberrations of mouse embryonic stem cells containing a single human chromosome 21 in neuronal differentiation: An in vitro model of down syndrome

15. Sonodynamically induced effect of rose bengal on isolated sarcoma 180 cells.

16. Structures and Biological Properties of DNA Adducts Derived from N-Nitroso Bile Acid Conjugates

17. Analysis of HPRT and supF Mutations Caused by Pierisin-1, a Guanine Specific ADP-Ribosylating Toxin Derived from the Cabbage Butterfly

18. Effect of chlorpromazine on intestinal absorption of sulfamethoxazole in rats

19. Structure of DNA Adduct Formed with Aminophenylnorharman, Being Responsible for the Comutagenic Action of Norharman with Aniline

23. The effect of dosage form on absorption of vitamin A into lymph

31. BRAF K601E-mutated metastatic colorectal cancer in response to combination therapy with encorafenib, binimetinib, and cetuximab: A case report.

32. Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer.

33. Unanticipated pathological clearance in two cases of clinical T4b dMMR/MSI-h advanced colorectal cancer: the potential of immune checkpoint inhibitors despite positive positron-emission tomography results.

35. Osteopontin secreted from obese adipocytes enhances angiogenesis and promotes progression of pancreatic ductal adenocarcinoma in obesity.

36. Clinical Impact of Proton Pump Inhibitor and Potassium-Competitive Acid Blocker for Predicting the Curability of Endoscopic Resection in Ulcerative Early Gastric Cancer.

37. [Influence of the Use of a Closed System Drug Transfer Device on the Preparation Time of Anticancer Drugs].

38. Characteristic endoscopic findings of gastrointestinal malignant lymphomas other than mucosa-associated lymphoid tissue lymphoma.

39. A Novel Urinary miRNA Biomarker for Early Detection of Colorectal Cancer.

40. Novel and Simple Criteria for Predicting Mortality of Peptic Ulcer Disease.

41. Urinary microRNA biomarkers for detecting the presence of esophageal cancer.

42. Safety and Evidence of Off-Label Use of Approved Drugs at the National Cancer Center Hospital in Japan.

43. Relationship between Immunophenotype and Clinicopathological Findings for Superficial Nonampullary Duodenal Epithelial Tumor.

44. Serum Exosomal Dicer Is a Useful Biomarker for Early Detection of Differentiated Gastric Adenocarcinoma.

45. Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response.

46. Monosodium glutamate ingestion during the development period reduces aggression mediated by the vagus nerve in a rat model of attention deficit-hyperactivity disorder.

47. Disorganization of Oligodendrocyte Development in the Layer II/III of the Sensorimotor Cortex Causes Motor Coordination Dysfunction in a Model of White Matter Injury in Neonatal Rats.

48. Discovery of Novel and Potent Stearoyl Coenzyme A Desaturase 1 (SCD1) Inhibitors as Anticancer Agents.

49. In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor.

50. Dysfunction in Motor Coordination in Neonatal White Matter Injury Model Without Apparent Neuron Loss.